UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

mTORC1 Inhibition Corrects Neurodevelopmental and Synaptic Alterations in a Human Stem Cell Model of Tuberous Sclerosis

Cell reports (Cambridge), 2016-04, Vol.15 (1), p.86-95

2016

Volltextzugriff (PDF)

Agonist-activated Ca²⁺ influx occurs at stable plasma membrane and endoplasmic reticulum junctions

Journal of cell science, 2010-12, Vol.123 (23), p.4170-4181

2010

Volltextzugriff (PDF)

Ryanodine Receptor Activation by Cav1.2 Is Involved in Dendritic Cell Major Histocompatibility Complex Class II Surface Expression

The Journal of biological chemistry, 2008-12, Vol.283 (50), p.34913-34922

2008

Volltextzugriff (PDF)

SRP-35, a newly identified protein of the skeletal muscle sarcoplasmic reticulum, is a retinol dehydrogenase

Biochemical journal, 2012-01, Vol.441 (2), p.731-741

2012

Volltextzugriff (PDF)

Patient, caregiver, and physician preferences for treatment of relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e18710-e18710

2022

Volltextzugriff (PDF)

Preferences and Perceptions Regarding Treatment Decision-Making for Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)

Blood, 2021-11, Vol.138 (Supplement 1), p.1928-1928

2021

Volltextzugriff (PDF)

Poster: ABCL-405 Patient, Caregiver, and Physician Preferences for Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)

Clinical lymphoma, myeloma and leukemia, 2022-10, Vol.22, p.S169

2022

Volltextzugriff (PDF)

ABCL-405 Patient, Caregiver, and Physician Preferences for Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)

Clinical lymphoma, myeloma and leukemia, 2022-10, Vol.22, p.S376-S377

2022

Volltextzugriff (PDF)

Realmind: A Prospective and Retrospective Study to Characterize Real-World Use of Tafasitamab Plus Lenalidomide in US Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma, with a Focus on Patients from Minority Groups

Blood, 2023-11, Vol.142 (Supplement 1), p.6251-6251

2023

Volltextzugriff (PDF)

Estimates of Survival and Life Expectancy with Tafasitamab Plus Lenalidomide in the L-Mind Study Compared with Real-World Standard-of-Care for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Blood, 2023-11, Vol.142 (Supplement 1), p.6286-6286

2023

Volltextzugriff (PDF)

Realmind: A Prospective, Multicenter, Observational Study of Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Starting Second- or Third-Line Therapy and Not Receiving Autologous Stem Cell Transplant

Blood, 2021-11, Vol.138 (Supplement 1), p.5010-5010

2021

Volltextzugriff (PDF)

Real-World Use of Tafasitamab for Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) in the United States by Age Group (>70 Years and ≤70 Years)

Clinical lymphoma, myeloma and leukemia, 2024-09, Vol.24, p.S213-S213

2024

Volltextzugriff (PDF)

ABCL-206 Real-World Use of Tafasitamab for Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) in the United States by Age Group (>70 Years and ≤70 Years)

Clinical lymphoma, myeloma and leukemia, 2024-09, Vol.24, p.S463-S464

2024

Volltextzugriff (PDF)

Minor sarcoplasmic reticulum membrane components that modulate excitation–contraction coupling in striated muscles

The Journal of physiology, 2009-07, Vol.587 (13), p.3071-3079

2009

Volltextzugriff (PDF)

Frequent Calcium Oscillations Lead to NFAT Activation in Human Immature Dendritic Cells

The Journal of biological chemistry, 2010-05, Vol.285 (21), p.16003-16011

2010

Volltextzugriff (PDF)

ABCL-051 realMIND: A Prospective, Multicenter, Observational Study of Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma Starting Second/Third-Line Therapy and Not Receiving a Stem Cell Transplant

Clinical lymphoma, myeloma and leukemia, 2022-10, Vol.22, p.S355-S356

2022

Volltextzugriff (PDF)

Poster: ABCL-051 realMIND: A Prospective, Multicenter, Observational Study of Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma Starting Second/Third-Line Therapy and Not Receiving a Stem Cell Transplant

Clinical lymphoma, myeloma and leukemia, 2022-10, Vol.22, p.S171

2022

Volltextzugriff (PDF)

Increasing the number of diagnostic mutations in malignant hyperthermia

Human mutation, 2009-04, Vol.30 (4), p.590-598

2009

Volltextzugriff (PDF)

Fibroblast growth factor 2 and platelet‐derived growth factor, but not platelet lysate, induce proliferation‐dependent, functional class II major histocompatibility complex antigen in human mesenchymal stem cells

Arthritis & rheumatology (Hoboken, N.J.), 2010-12, Vol.62 (12), p.3815-3825

2010

Volltextzugriff (PDF)

An RYR1 mutation associated with malignant hyperthermia is also associated with bleeding abnormalities

Science signaling, 2016-07, Vol.9 (435), p.ra68

2016

Volltextzugriff (PDF)

Downstream Effects of a RyR1 Mutation Linked to Malignant Hyperthermia on the Phenotypic and Functional Characteristic of Dendritic Cells

Biophysical journal, 2012-01, Vol.102 (3), p.307a-307a

2012

Volltextzugriff (PDF)

Physiological Role(S) of RyR1 in Smooth Muscle Cells

Biophysical journal, 2013-01, Vol.104 (2), p.443a-444a

2013

Volltextzugriff (PDF)

Gain of function in the immune system caused by a ryanodine receptor 1 mutation

Journal of cell science, 2013-08, Vol.126 (Pt 15), p.3485-3492

2013

Volltextzugriff (PDF)

Enhanced dihydropyridine receptor calcium channel activity restores muscle strength in JP45/CASQ1 double knockout mice

Nature communications, 2013, Vol.4 (1), p.1541-1541, Article 1541

2013

Volltextzugriff (PDF)

Functional Properties of RYR1 Mutations Identified in Swedish Patients with Malignant Hyperthermia and Central Core Disease

Anesthesia and analgesia, 2010-07, Vol.111 (1), p.185-190

2010

Volltextzugriff (PDF)

1 – 25 von 43

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(41)

Publikationsform

Artikel
(43)

Sprache

Englisch
(43)

Erscheinungsjahr

n.n

Thema

Science & Technology
(17)
Life Sciences & Biomedicine
(16)
Humans
(15)
Animals
(7)
Calcium - Metabolism
(7)
Cell Biology
(7)
Female
(5)
Ryanodine Receptor Calcium Release Channel - Genetics
(5)
Biochemistry & Molecular Biology
(4)
Cells, Cultured
(4)
Malignant Hyperthermia - Genetics
(4)
Mice
(4)
Mutation
(4)
Ryanodine Receptor Calcium Release Channel - Metabolism
(4)
Abcl
(3)
Biological And Medical Sciences
(3)
Cell Line
(3)
Dendritic Cells - Metabolism
(3)
Genetics & Heredity
(3)
Male
(3)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

mTORC1 Inhibition Corrects Neurodevelopmental and Synaptic Alterations in a Human Stem Cell Model of Tuberous Sclerosis

Agonist-activated Ca²⁺ influx occurs at stable plasma membrane and endoplasmic reticulum junctions

Ryanodine Receptor Activation by Cav1.2 Is Involved in Dendritic Cell Major Histocompatibility Complex Class II Surface Expression

SRP-35, a newly identified protein of the skeletal muscle sarcoplasmic reticulum, is a retinol dehydrogenase

Patient, caregiver, and physician preferences for treatment of relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL)

Preferences and Perceptions Regarding Treatment Decision-Making for Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)

Poster: ABCL-405 Patient, Caregiver, and Physician Preferences for Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)

ABCL-405 Patient, Caregiver, and Physician Preferences for Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)

Realmind: A Prospective and Retrospective Study to Characterize Real-World Use of Tafasitamab Plus Lenalidomide in US Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma, with a Focus on Patients from Minority Groups

Estimates of Survival and Life Expectancy with Tafasitamab Plus Lenalidomide in the L-Mind Study Compared with Real-World Standard-of-Care for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Realmind: A Prospective, Multicenter, Observational Study of Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Starting Second- or Third-Line Therapy and Not Receiving Autologous Stem Cell Transplant

Real-World Use of Tafasitamab for Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) in the United States by Age Group (>70 Years and ≤70 Years)

ABCL-206 Real-World Use of Tafasitamab for Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) in the United States by Age Group (>70 Years and ≤70 Years)

Minor sarcoplasmic reticulum membrane components that modulate excitation–contraction coupling in striated muscles

Frequent Calcium Oscillations Lead to NFAT Activation in Human Immature Dendritic Cells

ABCL-051 realMIND: A Prospective, Multicenter, Observational Study of Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma Starting Second/Third-Line Therapy and Not Receiving a Stem Cell Transplant

Poster: ABCL-051 realMIND: A Prospective, Multicenter, Observational Study of Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma Starting Second/Third-Line Therapy and Not Receiving a Stem Cell Transplant

Increasing the number of diagnostic mutations in malignant hyperthermia

Fibroblast growth factor 2 and platelet‐derived growth factor, but not platelet lysate, induce proliferation‐dependent, functional class II major histocompatibility complex antigen in human mesenchymal stem cells

An RYR1 mutation associated with malignant hyperthermia is also associated with bleeding abnormalities

Downstream Effects of a RyR1 Mutation Linked to Malignant Hyperthermia on the Phenotypic and Functional Characteristic of Dendritic Cells

Physiological Role(S) of RyR1 in Smooth Muscle Cells

Gain of function in the immune system caused by a ryanodine receptor 1 mutation

Enhanced dihydropyridine receptor calcium channel activity restores muscle strength in JP45/CASQ1 double knockout mice

Functional Properties of RYR1 Mutations Identified in Swedish Patients with Malignant Hyperthermia and Central Core Disease

Suchergebnisse filtern